CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Emad, Ali ^a   Emad, Yasaman ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MUSTARD GAS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRONCHIECTASIS; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOMETRY; HUMAN; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; PHENOTYPE;

EID: 33846482571     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-2     Document Type: Article

References (57)

1. Chemical warfare agents: their past and continuing threat and evolving therapies. KJ Smith H Skelton, Part I Skin Med 2003 2 215 21
2. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. JC Dacre M Goldman, Pharmacol Rev 1996 48 289 326 8804107
3. Battlefield chemical inhalation injury. JS Urbannetti, Pathophysiology and Treatment of Inhalation Injuries New York: Dekker, Luke J, 1988 34 281 348 (Lung Biol Health Dis Ser)
4. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. A Emad GR Rezaian, Chest 1997 112 734 738 9315808
5. Imaging the airways. Hemoptysis, bronchiectasis and small airways disease. AD Tasker CDR Flower, Clin Chest Med 1999 20 761 73 10.1016/S0272-5231(05)70254-9 10587797
6. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society, Am Rev Respir Dis 1991 144 1202 1218 1952453
7. Standardization of spirometry-1987 update. R Gardner J Kankinson J Clausen R Crapo R Johnson, Am Rev Respir Dis 1987 136 1285 98 3674589
8. Lung function in children and adolescence: methods, reference values. A Zapletal M Samanek T Paul, Progr Respir Res 1987 22 113 218
9. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. DB Reiff AU Wells DH Carr PJ Cole DM Hansell, A J R 1995 165 261 267
10. Relative abundance and patterns of correlation among six cytokines in pleural fluid measured by cytometric bead array. K Aoe A Hiraki T Murakami K Murakami K Makihata K Takao R Eda T Maeda K Sugi Z Darzynkiewicz H Takeyama, Int J Mol Med 2003 12 193 198 12851716
11. Long-term effects of chemical weapons on respiratory tract in Iraq-Iran war victims living in Babol (North of Iran). KH Bijani AA Moghadamnia, Ecotoxicol Environ Saf 2002 53 422 424 10.1016/S0147-6513(02)00034-9 12485587
12. Immunopathology of experimental bronchiectasis. Lapa E Silva JR D Guerreiro B Noble LW Poulter PJ Cole, Am J Respir Cell Mol Biol 1989 1 297 304 2696517
13. Cells and cytokines in chronic bronchial infection. J Lapa e Silva Eller JR LW Poulter H Lode PJ Cole, Ann NY Acad Sci 1994 725 331 45 10.1111/j.1749-6632.1994.tb39816.x 8031005
14. Cytokines in innate host defense in the lung. RM Strieter JA Belperio MP Keane, J Clin Invest 2002 109 6 699 705 11901175 10.1172/JCI200215277
15. Cytokine-mediated inflammation in acute lung injury. RB Goodman J Pugin JS Lee MA Matthay, Cytokine Growth Factor Rev 2003 14 6 523 35 10.1016/S1359-6101(03)00059-5 14563354
16. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. M Pasparakis L Alexopoulou V Episkopou G Kollias, J Exp Med 1996 184 1397 411 10.1084/jem.184.4.1397 8879212
17. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. K Pfeffer T Matsuyama TM Kundig A Wakeham K Kishihara A Shahinian K Wiegmann PS Ohashi M Kronke TW Mak, Cell 1993 73 457 67 10.1016/0092-8674(93)90134-C 8387893
18. Differential expression of the tumor necrosis factor cachectin gene by blood and lung mononuclear phagocytes. Y Martinet K Yamauchi RG Crystal, Am Rev Respir Dis 1988 138 659 65 3202418
19. Release of tumor necrosis factor by human polymorphonuclear leukocytes. JY Djeu D Serbousek DK Blanchard, Blood 1990 76 1405 9 2207315
20. Production of tumor necrosis factor: cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. SS Sung JM Bjorndahl CY Wang HT Kao SM Fu, J Exp Med 1988 167 937 53 10.1084/jem.167.3.937 2965212
21. Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1beta. RM Strieter SW Chensue MA Basha TJ Standiford JP Lynch M Baggiolini, Am J Respir Cell Mol Biol 1990 2 321 326 2182081
22. Regulation of expression interleukin-6. Molecular and clinical studies. A Ray SB Tatter U Santhanam DC Helfgott LT May PB Sehgal, Ann NY Acad Sci 1989 557 353 61 2786700
23. Interleukin-6 suppression of neutrophils apoptosis is neutrophil concentration dependent. WL Biffl EE Moore FA Moore CC Barnett Jr, J Leukoc Biol 1995 58 582 4 7595060
24. Evaluation of inflammatory cytokine secretion by human alveolar macrophages. JE Losa Garcia FM Rodriguez MR Martin de Cabo MJ Garcia Salgado JP Losada LG Villaron AJ Lopez JL Arellano, Mediators Inflamm 1999 8 143 51
25. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. WJ Ming L Bersani A Mantovani, J Immunol 1987 138 1469 74 3805724
26. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. C Schultz K Wolf M Harth K Krätzel L Kunz- Schughart M Pfeifer, Respiration 2003 70 254 261 10.1159/000072006 12915744
27. Interleukin- 8: differential expression in lone fibrosing alveolitis and systemic sclerosis. A Southcott A Jones S Majumdar A Cambrey C Pantelidis C Black G Laurent B Davies P Jeffery R duBois, Am J Respir Crit Care Med 1995 151 1604 1612 7735620
28. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. SG Folkard J Westwick AB Millar, Eur Respir J 1997 10 2097 104 10.1183/09031936.97.10092097 9311510
29. Cytokines of the lung. J Kelley, Am Rev Respir Dis 1990 141 765 88 2155556
30. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. VM Keatings PD Collins DM Scott PJ Barnes, Am J Respir Crit Care Med 1996 153 530 534 8564092
31. In vitro prevention and reversal of lipopolysaccharide desensitization by INF-g, IL-12, and granulocyte-macrophage colony-stimulating factor. F Randow WD Do Cke DS Bundschuh T Hartung A Wendel HD Volk, J Immunol 1997 158 2911 18 9058829
32. Interleukin 10 inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. A D'Andrea M Aste-amezaga NM Valiante X MA M Kubin G Trinchieri, J Exp Med 1993 178 1041 8 10.1084/jem.178.3.1041 8102388
33. A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture. L Wimberley LJ Falling JG Bartlett, Am Rev Respir Dis 1979 119 337 43 375784
34. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. H Cabello A Torres R de Celis M El-Elbiary J Puig de la Bellacasa A Xaubet J Gonzalez C Agustí N Soler, Eur Respir J 1997 10 1137 1144 10.1183/09031936.97.10051137 9163659
35. Inflammatory Mediators in Cystic Fibrosis Lung Disease Allergy Asthma Proc. M Berqer, 2002 23 19 25
36. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airways mucosa. C Hubeau M Lorenzato JP Couetil D Hubert D Dusser E Puchelle D Gaillard, Clin Exp Immunol 2001 124 69 76 10.1046/j.1365-2249.2001. 01456.x 11359444
37. The role of inflammation in the pathophysiology of CF lung disease. JF Chmiel M Berger MW Konstan, Clin Rev Allergy Immunol 2002 23 5 27 10.1385/CRIAI:23:1:005 12162106
38. Bronchiectasis in Pediatric AIDS. S Sheikh K Madiraju P Steiner M Rao, Chest 1997 112 1202 1207 9367458
39. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. H Mukae J Kadota S Kohno S Kusano T Morikawa S Matsukura K Hara, Am J Respir Crit Care Med 1995 152 2 613 8 7633715
40. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. M Gaga AM Bentley M Humbert J Barkans F O'Brien CG Wathen AB Kay SR Durham, Thorax 1998 53 685 691 9828857
41. Pathology produced by sulfur mustard in human skin grafts on athymic nude mice. II. Ultrastructural changes. B Papirmeister CL Gross JP Petrali HL Meier, J Toxicol Cutaneous Ocul Toxicol 1984 3 393 408
42. NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard. MA Mol Ruit van de AW Kluivers, Toxicol Appl Pharmacol 1989 98 156 65 10.1016/0041-008X(89)90143-9
43. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures. FM Cowan JJ Yourick CG Hurst C Broomfield WJ Smith, Cell Biol Toxicol 1993 9 269 77 10.1007/BF00755605 8299005
44. Toxic effects of sulfur mustard on respiratory epithelial cells in culture. M Chevillard P Lainee P Robineau E Puchelle, Cell Biol Toxicol 1992 8 171 81 10.1007/BF00260566 1422926
45. Cellular and molecular immunology. AK Abbas AH Lichtman JS Pober, Saunders Text and Review Series New York, NY WB Saunders 4 2000 291 308
46. Lymphocyte-mediated cytolysis and disease. L Chau-Ching LHY Young JDE Young, N Engl J Med 1996 335 1651 1659 10.1056/NEJM199611283352206 8929363
47. Differences in Airway Remodeling Between Asthma and Chronic Obstructive Pulmonary Disease. K Aoshiba A Nagai, Clin Rev Allergy Immunol 2004 27 35 43 10.1385/CRIAI:27:1:035 15347849
48. Increased in CD8 T lymphocytes in the BAL fluid of patients with sulfur mustard gas-induced pulmonary fibrosis. A Emad Y Emad, Respir Med 2006, Sep 16
49. Remodeling in asthma and chronic obstructive lung disease. PK Jeffery, Am J Respir Crit Care Med 2001 164 S28 S38 11734464
50. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. RE Russell SV Culpitt C DeMatos L Donnelly M Smith J Wiggins PJ Barnes, Am J Respir Cell Mol Biol 2002 26 602 609 11970913
51. Alveolar inflammation and its relationship to emphysema in smokers. R Finkelstein RS Fraser H Ghezzo MG Cosio, Am J Respir Crit Care Med 1995 152 1666 1672 7582312
52. Local and systemic inflammation in patients with chronic obstructive pulmonary disease. Soluble tumour necrosis factor receptors are increased in sputum. JH Vernooy M Kucukaycan JA Jacobs NH Chavannes WA Buurman MA Deventener EF Wouters, Am J Respir Crit Care Med 2002 166 1218 1224 10.1164/rccm.2202023 12403691
53. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Y Ichikawa H Ninomiya H Koga M Tanaka M Kinoshita N Tokunaga T Yano K Oizumi, Am Rev Respir Dis 1992 146 196 203 1626803
54. Macrolides as biological response modifiers in cystic fibrosis and bronchiectasis. A Bush BK Rubin, Semin Respir Crit Care Med 2003 24 737 48 10.1055/s-2004-815669 16088589
55. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis. ML Everard P Sly S Brenan G Ryan, Eur Respir J 1997 10 2926 10.1183/09031936.97.10122926 9493687
56. Improvement of respiratory symptoms by long-term low-dose erythromycin in sulfur mustard exposed cases: A pilot study. M Ghanei M Ghasem zadeh M Shohrati, J Med C B R Def 2005 3 1 9
57. Efficacy of concomitant administration of clarithromycin and acetylcysteine in bronchiolitis obliterans in seventeen sulfur mustard-exposed patients: An open-label study. M Ghanei A Kamran J Aslani, Current therapeutic research 2004 65 495 504 10.1016/j.curtheres.2004.12.001